Congressional Stock Trading Debate Reignites as Johnson Defends Lawmaker Salaries Otter Tail OTTR Q1 2026 Earnings 173 EPS Surges Past 144 Estimates Willdan Group WLDN Stock Analysis Flat at 8870 Whats Next 20260519 JDcom JD Gains 266 Support Holds at 3082 20260519 New York City Mayor Mamdani Responds to Bezos on Billionaire Tax Impact OBOOK OWLS Climbs 452 Resistance at 620 in Focus 20260520 Ainos AIMD Earnings Outlook Key Metrics for Q1 2025 Novo Nordisk Doubles Down on Oral Wegovy as Global WeightLoss Drug Competition Heats Up SP 500 Rises as Tech Surge Offsets Energy and Defensive Weakness OpenAI Sets Sights on IPO as AI Competition Heats Up Confidential Filing Reportedly Imminent Nationwide Faces Governance Concerns as Labour MP Raises Issues Before AGM Prairie Operating PROP Faces NearTerm Headwinds But Bullish Thesis Remains Intact Eli Lillys NextGeneration Obesity Drug Retatrutide Shows Positive Results in Pivotal Trial Shein Acquires Everlane Ethical Luxury Brand Joins FastFashion Giant TDOC Q1 2026 Earnings EPS Misses Expectations as Teladoc Reports WiderThanAnticipated Loss CIMP Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Performance DLTH Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher GENB Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates Shares Rise on Operational Progress PLCE Q1 2026 Earnings EPS Misses by Wide Margin as Headwinds Persist Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline Finward Bancorp FNWD Q1 2026 Earnings EPS Misses Expectations but Stock Ticks Higher MainStreet Bancshares Inc MNSB Q1 2026 Earnings Strong EPS Beat Surprises Analysts BRLT Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Modest Stock Gain Chicago Atlantic Real Estate Finance Inc REFI Q1 2026 Earnings Earnings Miss Estimates Amid Higher Expenses PANW Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction as Cybersecurity Demand Remains Robust SP 500 Edges Higher as Tech Surge Offsets Energy Slump DSGN Q1 2026 Earnings EPS Beats Estimates as Development Stage Biotech Advances Pipeline